Last updated:
A recent report issued by the National Joint Registry for England and Wales cites an increase in failure rates of all-metal artificial hip devices, according to a recent article published by the New York Times. The report states that a version of the Johnson & Johnson ASR all-metal hip device sold in Britain has failed in approximately one-third of the 2,100 patients followed by the joint registry in the past six years. Approximately 17% of the individuals in this same group have experienced device failure at the five-year mark. These alarming failure rates have strong implications for U.S. patients implanted with the similar ASR metal hip device.
The British registry further reports that all-metal hip devices in general have a higher rate of early failure when compared to other types of hip devices manufactured with a combination of different materials (such as metal and plastic). In the past year, the U.S. has further scrutinized all-metal hip implants. The FDA, in particular, has required all-metal hip implant device manufacturers to conduct studies examining the increased failure rates in this type of hip implant.
According to the British report, the release of chromium and cobalt particles into the blood is one of the causes of the increase in early failure rates of all-metal hip devices. The wear associated with metal hip devices as time passes causes the release of these particles into the body. Although the release of metal into the body may not be life threatening, it has the potential to cause injuries that can further debilitate the hip patient.
See the full New York Times article at:
http://www.nytimes.com/2011/09/16/health/16hip.html
National Joint Registry, 8th Annual Report 2011:
http://www.njrcentre.org.uk/NjrCentre/Portals/0/Documents/NJR%208th%20Annual%20Report%202011.pdf
Hurt in a dangerous drugs & devices situation?
Talk directly with John David Hart — board-certified Texas trial lawyer. Free, confidential, no fee unless we win.
Get a Free Case Review Call 817-870-2102More on Dangerous Drugs & Devices
How we handle Dangerous Drugs & Devices →Centric Compounding Recall: Glutathione, Myers’ Cocktail, and Tri-Immune Boost Lots
Quick answer: In September 2026, Centric Compounding of Houston, Texas recalled six lots of injectable vials: three of Glutathione 200 mg/mL, two…
Continue reading »Optimal Balance Pharmacy Glutathione Recall: Lot LG342009076 Shipped to 14 States
Quick answer: On August 19, 2026, Optimal Balance Pharmacy of Houston, Texas recalled one lot of compounded glutathione injection, lot LG342009076, after…
Continue reading »Victory Medical Center Pharmacy Glutathione Recall: Lots, Symptoms, and the Lawsuit
Quick answer: On August 5, 2026, Victory Medical Center Pharmacy of Austin, Texas recalled three lots of compounded glutathione 200 mg/mL after…
Continue reading »